Inhibin and the regulation of bone mass

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Osteoporosis Reports

• Publication date

  2008-10-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/S11914-008-0009-5PMID 18778563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor*

  2008cited by this paper
• A Population‐Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and Men

  2007cited by this paper
• Inhibin A is an endocrine stimulator of bone mass and strength.

  2007cited by this paper
• Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.

  2006cited by this paper
• Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

  2006cited by this paper
• Glucocorticoids suppress bone formation via the osteoclast.

  2006cited by this paper
• Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.

  2006cited by this paper
• FSH directly regulates bone mass.

  2006cited by this paper
• Osteoclast-derived activity in the coupling of bone formation to resorption.

  2005cited by this paper
• Ovarian aging and bone metabolism in menstruating women aged 35-50 years.

  2005cited by this paper
• Parathyroid hormone: past and present.

  2005cited by this paper
• Parathyroid hormone - a bone anabolic and catabolic agent.

  2005cited by this paper
• Population‐Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites

  2004cited by this paper
• Activins and Inhibins and Their Signaling

  2004cited by this paper
• Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin.

  2004cited by this paper
• Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.

  2004cited by this paper
• Molecular biology of inhibin action.

  2004cited by this paper
• Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression

  2002cited by this paper
• Hormonal changes in the menopause transition.

  2002cited by this paper
• Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures.

  2002cited by this paper
• Endocrine causes of age-related bone loss and osteoporosis.

  2002cited by this paper
• Sex steroids and bone.

  2002cited by this paper
• Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.

  2001cited by this paper
• Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β Superfamily

  2001cited by this paper
• Regulable expression of inhibin A in wild-type and inhibin alpha null mice.

  2000cited by this paper
• Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

  2000cited by this paper
• Primary osteoporosis in men: role of sex steroid deficiency.

  2000cited by this paper
• Regulable Expression of Inhibin A in Wild-Type and Inhibinα Null Mice

  2000cited by this paper
• Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.

  2000cited by this paper
• Does estrogen stimulate osteoblast function in postmenopausal women?

  1999cited by this paper
• High‐Dose Estrogen Induces De Novo Medullary Bone Formation in Female Mice

  1999cited by this paper
• Female reproductive aging is marked by decreased secretion of dimeric inhibin.

  1999cited by this paper
• A Prospective Study of Bone Loss in Menopausal Australian-Born Women

  1998cited by this paper
• Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

  1998cited by this paper
• Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

  1998cited by this paper
• Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence.

  1997cited by this paper
• Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.

  1997cited by this paper
• Bone turnover markers and bone density across the menopausal transition.

  1996cited by this paper
• Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles.

  1996cited by this paper
• Measurement of dimeric inhibin B throughout the human menstrual cycle.

  1996cited by this paper
• PTH: A future role in the management of osteoporosis?

  1996cited by this paper
• Glucocorticoids induce mineralization coupled with bone protein expression without influence on growth of a human osteoblastic cell line.

  1995cited by this paper
• Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone

  1991cited by this paper
• A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.

  1988cited by this paper
• The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation.

  1976cited by this paper
• The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation.

  1976cited by this paper

• Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.

  2022cites this paper
• Estrogen versus FSH Effects on Bone Metabolism: Evidence From Interventional Human Studies.

  2020cites this paper
• Possible link between FSH and RANKL release from adipocytes in men with impaired gonadal function including Klinefelter syndrome.

  2019cites this paper
• Activin-βC modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways

  2015cites this paper
• Early bone mineral density decrease is associated with FSH and LH, not estrogen.

  2013cites this paper
• Control of Bone Resorption by Semaphorin 4D Is Dependent on Ovarian Function

  2011cites this paper
• Signaling pathways implicated in androgen regulation of endocortical bone.

  2010cites this paper
• Inhibins: from reproductive hormones to tumor suppressors.

  2010cites this paper
• Follicle-stimulating hormone increases bone mass in female mice

  2010cites this paper
• Understanding estrogen action during menopause.

  2009cites this paper